Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001448
Filing Date
2024-08-14
Accepted
2024-08-14 16:30:55
Documents
59
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q snpx-20240630x10q.htm   iXBRL 10-Q 1876830
2 EX-31.1 snpx-20240630xex31d1.htm EX-31.1 9695
3 EX-31.2 snpx-20240630xex31d2.htm EX-31.2 9757
4 EX-32.1 snpx-20240630xex32d1.htm EX-32.1 4993
5 EX-32.2 snpx-20240630xex32d2.htm EX-32.2 5076
  Complete submission text file 0001410578-24-001448.txt   6452907

Data Files

Seq Description Document Type Size
6 EX-101.SCH snpx-20240630.xsd EX-101.SCH 56474
7 EX-101.CAL snpx-20240630_cal.xml EX-101.CAL 29947
8 EX-101.DEF snpx-20240630_def.xml EX-101.DEF 187515
9 EX-101.LAB snpx-20240630_lab.xml EX-101.LAB 421527
10 EX-101.PRE snpx-20240630_pre.xml EX-101.PRE 319830
62 EXTRACTED XBRL INSTANCE DOCUMENT snpx-20240630x10q_htm.xml XML 808140
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40458 | Film No.: 241208623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)